Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Pazopanib
Drug ID BADD_D01687
Description Pazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.
Indications and Usage Treatment of advanced renal cell cancer and advanced soft tissue sarcoma (in patients previously treated with chemotherapy)
Marketing Status Prescription; Discontinued
ATC Code L01EX03
DrugBank ID DB06589
KEGG ID D05380
MeSH ID C516667
PubChem ID 10113978
TTD Drug ID Not Available
NDC Product Code Not Available
Synonyms pazopanib | GW 786034B | GW786034B | GW-786034B | GW 780604 | GW780604 | GW-780604 | Votrient
Chemical Information
Molecular Formula C21H23N7O2S
CAS Registry Number 444731-52-6
SMILES CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anxiety19.06.02.002--
Aortic dissection24.02.03.0020.000799%Not Available
Aphasia19.21.01.001; 17.02.03.001--
Aphonia19.19.01.002; 17.02.08.009; 22.02.05.0240.001066%
Aphthous ulcer07.05.06.0020.001066%Not Available
Arrhythmia02.03.02.001--Not Available
Arterial thrombosis24.01.01.0020.000533%Not Available
Arteriovenous fistula24.03.03.0010.000533%Not Available
Arthralgia15.01.02.001--
Arthritis15.01.01.001--
Ascites09.01.05.003; 07.07.01.001; 02.05.04.0020.005062%
Aspartate aminotransferase decreased13.03.01.0050.000533%Not Available
Aspartate aminotransferase increased13.03.01.0060.015718%
Asphyxia22.02.02.001; 12.01.08.0110.000208%Not Available
Asthenia08.01.01.0010.038363%Not Available
Asthma22.03.01.002; 10.01.03.010--Not Available
Atrial fibrillation02.03.03.002--
Atrial flutter02.03.03.003--
Atrioventricular block02.03.01.0020.001066%Not Available
Back pain15.03.04.0050.012521%
Bacteraemia11.01.11.0010.000139%
Bile duct stone09.02.02.0030.000533%Not Available
Bladder pain20.02.02.0010.000533%Not Available
Blindness17.17.01.003; 06.02.02.001--Not Available
Blindness transient17.17.01.004; 06.02.02.0020.000533%Not Available
Blister23.03.01.001; 12.01.06.0020.007193%Not Available
Blood albumin decreased13.09.01.0010.001865%Not Available
Blood albumin increased13.09.01.002--Not Available
Blood bilirubin increased13.03.01.0080.011988%
Blood calcium decreased13.11.01.002--Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 28 Pages